Latest news

Stocks Fall on Retail Sales Reports

Stocks headed down today as retailers reported poor sales last month and even titan Wal-Mart failed to meet expectations.

08.01.2009 16:32:59 - washingtonpost.com - Business

Powermat cuts ties with cabled power

Wireless charging for phones and laptops

CES Power sockets clogged with gadget chargers and swamped by a cable spaghetti will soon be just a memory, if Powermat has its way.…

08.01.2009 16:17:36 - The Register

Virus peddlers set up shop on Google code project

Skin-flick codec scams follow MSN Spaces abuse

Internet scoundrels have begun abusing Google code hosting projects to distribute malware and promote smut. The assault follows a bout of the same kind of abuse against Microsoft's comparable MSN Spaces beta site dating back a year, net security firm McAfee reports.…

08.01.2009 16:13:39 - The Register

US doc demands $1.5m for donated organ

Missus runs off with kids, kidney

A US doctor is demanding his ex-missus stump $1.5m after she ran off with their three kids and one of his kidneys, the New York Daily News reports.…

08.01.2009 16:00:37 - The Register

Enbrel Approved For Children With Psoriasis, Europe

The European Commission has granted marketing authorisation of the use of Enbrel® (etanercept) as the first biologic licensed for treatment in children and adolescents with chronic severe plaque psoriasis.

08.01.2009 16:00:00 - Health News from Medical News Today

Cambridge Temperature Concepts Gains Medical Approval For Revolutionary Fertility Monitor DuoFertility And Ships First Units

Cambridge Temperature Concepts (CTC) announced receiving medical approval for their revolutionary non-invasive fertility monitor - DuoFertility. CTC have now begun shipping DuoFertility monitors to one hundred couples across Europe, selected by the Company to trial the device and give feedback on its usability and design before product launch.

08.01.2009 16:00:00 - Health News from Medical News Today

Positive Results For Peplin's Phase IIb AK Trial

Peplin, Inc. (ASX:PLI) announced positive results with its lead product candidate PEP005 (ingenol mebutate) Gel in its Phase IIb actinic (solar) keratosis (AK) dose ranging clinical trial (PEP005-015) for the treatment of AK lesions on head locations, which comprise the face and scalp. AK is a common pre-cancerous skin condition caused by sun exposure.

08.01.2009 16:00:00 - Health News from Medical News Today

BioMimetic Therapeutics, Inc. Closes Enrollment With 436 Patients In North American Pivotal Study For Augment™ Bone Graft

BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced that as of December 31, 2008, 436 patients were enrolled in the Company's North American pivotal clinical study for its lead orthopedic product candidate Augment™ Bone Graft.

08.01.2009 16:00:00 - Health News from Medical News Today

The Institute For Advanced Laser Dentistry Announces Impressive Line Up Of Speakers For 6TH Annual Clinicians' Meeting

The Institute for Advanced Laser Dentistry (IALD) announced its line up of industry-leading speakers for the highly anticipated 6th Annual Clinicians' Meeting, taking place February 11-15, 2009 (Valentine's and President's day weekend) at the luxurious Moon Palace Golf & Spa Resort in Cancun, Mexico.

08.01.2009 16:00:00 - Health News from Medical News Today

Ipsen: FDA's First-Cycle Review Of Reloxin(R) Extended

Ipsen (Paris:IPN) announced that the U.S. Food and Drug Administration (FDA) provided notification that the Prescription Drug User Fee Act (PDUFA) action date for Reloxin® (botulinum toxin of type A) Biologics License Application (BLA) in aesthetic indications (glabellar lines) has been extended to April 13, 2009. The FDA did not issue any specific request on the occasion of this extension.

08.01.2009 16:00:00 - Health News from Medical News Today